Senator grills Makary over FDA’s ability to regulate drug ads after OPDP cuts
In the wake of sweeping cuts at the FDA’s Office of Prescription Drug Promotion, Sen. Dick Durbin, D-Ill., is questioning how effectively the agency can continue to regulate pharmaceutical advertisements.
In the wake of sweeping cuts at the FDA’s Office of Prescription Drug Promotion, Sen. Dick Durbin, D-Ill., is questioning how effectively the agency can continue to regulate pharmaceutical advertisements.
